Biotest AG

Biotest AG is a biotechnology company that specializes in the development and marketing of plasma proteins and biotherapeutic drugs. The company's core business focuses on three main areas: clinical immunology, hematology, and intensive care medicine. Biotest produces a range of products derived from human plasma, including immunoglobulins, coagulation factors, and albumin, which are used to treat diseases of the immune system and hematopoietic systems. These products include intravenously applicable solutions for the treatment of severe bacterial infections, coagulation disorders, and volume or protein substitution, as well as preparations for the treatment of hemophilia A and B. Additionally, the company supplies human albumin as a multifunctional auxiliary material for biotechnological, pharmaceutical, and diagnostic applications.

Biotest - Innovation in haematology, clinical immunology and intensive care medicine.

Haematology
Haemoctin® SDH
Haemonine®

Clinical immunology
Yimmugo®
Cytotect® CP
Hepatect® CP
Varitect® CP
Intratect®
Zutectra®

Intensive Care Medicine
Albiomin®
Biseko®
Pentaglobin®

For manufacturing and research use
Biotest Human Serum Albumin